Welcome to the
Fitzsimons Redevelopment Authority
Colorado's $4.3 billion "square mile of life sciences" has become the launch pad, hub and focus for the biotechnology industry in the Rocky Mountain Region. The Colorado Bioscience Park Aurora is the first university affiliated "biopark" to be developed west of the Mississippi. It is adjacent to the University of Colorado Health Sciences Center and Hospital Complex, The Children's Hospital, and the Fitzsimons Commons town center. Together, these developments form a stimulating and interactive scientific entrepreneurial community.

	Building 500, the first structure to be renovated for reuse stands as a monument to the past and a beacon to the future of the Fitzsimons project.

Collaborations at Fitzsimons are facilitated by formal programs and informal encounters. Facilities, services and support give start-up and early stage bioscience companies the best possible opportunities to succeed. An affiliation agreement provides research park companies special consideration for access to university core labs and services. New buildings and development parcels at Fitzsimons can accommodate expansion-stage bioscience companies and pharmaceutical R&D operations within the campus setting.

Innovation is a central theme to the Fitzsimons community. The work of university research groups and institutes ranges from human anatomy simulations and biomaterials to new cardiovascular approaches to heart failure utilizing gene therapies. Private biotechnology companies are focused on a multitude of advances, among them: magnetically targeted chemotherapies to allow greater concentration at tumor sites, advanced methods for more accurate readings of mammograms, new treatments for Alzheimer's disease, anti-fungal, identification of genetic mutations that can increase crop yields and fight disease, and a new class of vaccines for AIDS and other infectious diseases.

Economic Development
Employment at Fitzsimons will reach 19,000 by 2010, with jobs in teaching, patient care, basic-science research and biotechnology research and development. Fitzsimons received the 2003 National Award for Excellence in Technology-Led Economic Development from the U.S. Department of Commerce, Economic Development Administration

	A panoramic view from the University of Colorado Hospital Anschutz Inpatient Pavillion capturing construction progress on the Fitzsimons campus as of January 2003.

Fitzsimons is one of several visionary initiatives of the City of Aurora, a city of 300,000 within the Aurora/Denver metro area that is asserting itself as a premier 21st-Century community for science and technology. Aurora's fast-paced emergence as a biotech center is happening along side civic investments and planned new communities, reflecting the livability and vitality of Colorado's urban Front Range

Of the 50 US states, Colorado ranks 2nd in potential for future technology growth. (Science and Technology Index, Milken Institute, September 2002). It has consistently been among the top five states for placement of venture capital. Colorado's biotech cluster has grown rapidly over the last ten years, with a mix of locally founded companies along sid operations of Amgen, OSI, Baxter and Roche.

The Fitzsimons Redevelopment Authority, City of Aurora and University of Colorado invite companies, research institutes and entrepreneurs to participate in the many biotech activities and events at Fitzsimons - and to consider the opportunities of a location in the largest medical-related redevelopment project in the nation.